Background: Breast cancer and chemotherapy undergone by the patient can cause a variety of mental emotional disorder such as depression and anxiety. Depression and
anxiety on patients with breast cancer can affect treatment compliance and taking
medication, and decreased quality of life.
Goals: Determining depression and anxiety on breast cancer patients undergoing chemotherapy in Dharmais Cancer Hospital.
Methods: This research is done cross-sectionally to 85 breast cancer patients undergoing chemotherapy in Dharmais Cancer Hospital on January 2016 – March
2016. This research uses demographic and physical condition questionnaire, Hamilton Rating Scale for Depression (HRSD), and Hamilton Rating Scale for
Anxiety (HAM-A).
Results: 85 breast cancer patients undergoing chemotherapy with age ranging from 30 to 70, 55,29% of 45-55 years old, 54.12% high school education, 72.94% housewives, 94.12% married, and 75.29% adequate economic status, 42.35% stage 4 breast cancer, 28.24% underwent chemotherapy for 3-4 months, with most side effects are hair loss (98.82%), nausea and vomiting (91.76%). 12.94% of respondents experiencing mild anxiety, 18.82% with depression; i.e. 16.47% mild depression and 2,35% moderate depression.
Conclusions: In this study, there were 18.82% depression and 12.94% anxiety on breast cancer patients undergoing chemotherapy in Dharmais Cancer Hospital, but depression and anxiety with severe level were not found. |